FDA Video: Pancreatitis in Patients Taking Byetta for Diabetes

Below is an excellent video published by the U.S. Food & Drug Administration (FDA), which warns patients of the link between pancreatitis and Byetta.

UPDATED: In October 2007, FDA warned healthcare professionals about reports of acute pancreatitis in patients taking the antidiabetic drug Byetta (exenatide). Since then, FDA has received reports of six cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta. Two were fatal.

Byetta and other suspect drugs should be promptly discontinued if pancreatitis is suspected. There are no known patient characteristics that can determine whether a case of pancreatitis associated with Byetta will develop into the hemorrhagic or necrotizing forms. If pancreatitis is confirmed, it should be treated without delay and the patient should be carefully monitored until recovery. Byetta should not be restarted. Physicians should consider antidiabetic therapies other than Byetta in patients who have a history of pancreatitis.

Additional Information:

• Byetta FDA Pancreatitis Warning

Do I Have a Byetta Lawsuit?

The Defective Drug & Products Liability Litigation Groups at our law firm are an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Byetta lawsuits. We are pursuing individual litigation nationwide and currently accepting new Byetta side effects and pancreatitis cases in all 50 states.

If you or a loved one have developed pancreatitis while taking Byetta, you should contact us immediately. You may be entitled to compensation for your injuries and we can help.